Solomon Langermann
- Endocrinology top 0.5%
- Escherichia coli research studies 11
- Microbiology top 0.5%
- Immunology top 2%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 8
- Immune cells in cancer 5
- Molecular Medicine top 2%
- Epidemiology top 2%
- Urinary Tract Infections Management 6
-
- Cancer Immunotherapy and Biomarkers 12
- CAR-T cell therapy research 5
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Jerome S. PinknerScott J. HultgrenDevapriya ChoudhuryStefan D. KnightSusan PalaszynskiScott KoenigJohn E. AdamouAndrew W. Thompson
- Cited by
- EndocrinologyMicrobiologyImmunology
- Journals
- Infection and Immunity (4 papers)The Journal of Infectious Diseases (4 papers)Molecular Microbiology (3 papers)
- Partner nations
- United StatesGreeceSweden
In The Last Decade
Solomon Langermann
53 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Endocrinology 911
- Microbiology 514
- Immunology 1.0k
- Molecular Medicine 224
- Epidemiology 984
Countries citing papers authored by Solomon Langermann
This map shows the geographic impact of Solomon Langermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solomon Langermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solomon Langermann more than expected).
Fields of papers citing papers by Solomon Langermann
This network shows the impact of papers produced by Solomon Langermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solomon Langermann. The network helps show where Solomon Langermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Solomon Langermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 40 | |
| 7 | 2023 | 2 | |
| 8 | Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapybreakdown → | 2019 | 488 |
| 9 | 2013 | 12 | |
| 10 | 2013 | 14 | |
| 11 | 2013 | 46 | |
| 12 | 2008 | 35 | |
| 13 | 2004 | 368 | |
| 14 | 2002 | 271 | |
| 15 | 2002 | 325 | |
| 16 | 2001 | 58 | |
| 17 | 2000 | 255 | |
| 18 | 1999 | 126 | |
| 19 | 1999 | 35 | |
| 20 | 1994 | 98 |
About Solomon Langermann
Solomon Langermann is a scholar working on Endocrinology, Immunology, Oncology, Microbiology and Epidemiology, having authored 55 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Escherichia coli research studies (11 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Urinary Tract Infections Management (6 papers), CAR-T cell therapy research (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Endocrinology (911 citations), Microbiology (514 citations), Immunology (1.0k citations), Molecular Medicine (224 citations) and Epidemiology (984 citations). Solomon Langermann has collaborated with scholars based in United States, Greece and Sweden. Frequent co-authors include Jerome S. Pinkner, Scott J. Hultgren, Devapriya Choudhury, Stefan D. Knight, Susan Palaszynski, Scott Koenig, John E. Adamou, Andrew W. Thompson, V. Stojanoff and Theresa M. Wizemann. Their work appears in journals such as Infection and Immunity, The Journal of Infectious Diseases, Molecular Microbiology, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.